.png){kind=logo}
GC Asia
Pfizer underscores insatiable demand theory
In what is becoming a familiar theme, US drug company Pfizer this week issued an acquisition related high grade bond that swiftly dropped to much lower yields after pricing.
It was priced only four weeks after Roche, another pharmaceutical, brought $16.5bn in the biggest US dollar bond offering yet.
This ...Already a subscriber? Login
-
Latest news from Corporate Bonds
-
Surrey Univ follows King’s into US PP market
14 Apr 2021 -
SGS’s aggressive approach lands debut at fair value
14 Apr 2021 -
Lloyds picks resources banker to lead ESG team
14 Apr 2021 -
Belgian Reit Montea sells green US private placements
14 Apr 2021 -
Hanwha Solutions sells Rmb1bn green dim sum
14 Apr 2021
-
-
Latest news from Corporate Bonds
-
Surrey Univ follows King’s into US PP market
14 Apr 2021 -
SGS’s aggressive approach lands debut at fair value
14 Apr 2021 -
Lloyds picks resources banker to lead ESG team
14 Apr 2021 -
Belgian Reit Montea sells green US private placements
14 Apr 2021 -
Hanwha Solutions sells Rmb1bn green dim sum
14 Apr 2021
-
